个股论点
围绕单一股票的投资逻辑与仓位表态 · 共 2504 条 · 滚到底自动加载更多
-
认为诺和诺德撤诉并合作 HIMS 让很多人措手不及
@alc2022 这事说得通，不过 $NVO 撤诉并转而和 $HIMS 合作，对大多数人来说确实是个意外。 这一下明显打了很多人一个措手不及，尤其是那些没回补、还以为 $HIMS 会完蛋的做空者。
英文原文
@alc2022 Makes sense though given $NVO dropping the lawsuit and partnering with $HIMS was a surprise to majority of people. Definitely caught a lot of people off guard, especially short sellers that didn’t cover and thought $HIMS was going under
-
认为 TSEM 比 TSM 更纯粹受益于光子起量
@zephyr_z9 没错，但和 $TSM 相比，$TSEM 对光子起量的纯度更高，而且估值只有它的 1/100。 可以说，这也意味着它有更快重估的潜力。
英文原文
@zephyr_z9 True, but $TSEM is more pure play to photonics ramp than $TSM, and at 1/100th the valuation. Arguably leads to faster re-rating potential
-
Huberman 点名 HIMS，进一步强化多头叙事
斯坦福神经科学家 Andrew Huberman，也是健康领域最有影响力的人物之一，刚刚公开点名了 $HIMS。 他还说，在一个非常现实的情景下，它有望“腾飞”。 不是每天都能看到这种“行走的医学广告牌”隐性在给 $HIMS 站台做多。 我很好奇，那些还在做空 41%+ 流通盘的人到底在想什么？
英文原文
Andrew Huberman, the Stanford neuroscientist and one biggest voices in the health, just spotlighted $HIMS. And said it was set to “soar” in a very realistic scenario. Not everyday do you have the walking billboard of medicine implicitly pitching $HIMS as a long. Curious what short sellers were thinking selling 41%+ of the float short?
-
等待财报看 openclaw 的消费需求能否拉动收入
@Andres17G 我还拿着仓位，等财报电话会议看看 openclaw 的消费端需求能不能把他们的总收入往上带一带。
英文原文
@Andres17G I’m still sitting on positions, waiting for earnings call to see if consumer demand segment from openclaw brings up their overall revenue
-
认为 Soitec 的重估空间比别的名字更大
@zzzpw4a 分散投资当然能降低风险。 集中配置通常更容易拿到更高回报。 在我看来，$SOI 由于起点更低，重估空间还更大。
英文原文
@zzzpw4a Diversification is always good for lower risk. Concentration is better for higher returns. IMO $SOI has more room to be re-rated given its starting point.
-
感谢媒体覆盖 Soitec，并确认自己的核心论点
这次终于感谢 MarketScreener 对 $SOI 的真实报道。 文章写道： “在专门讨论 Soitec 的帖子里，作者提出了几个论点。他认为，该集团可能受益于 CPO（共封装光学）的发展，而 CPO 是为伴随人工智能和数据中心崛起而设计的一种光子架构。根据他的说法，Soitec 在该技术所用的某些 SOI 衬底上拥有近乎垄断的地位，如果光子技术被大规模采用，这一优势可能变得具有战略意义。该投资者还提到，他认为估值水平偏低，并相信到 2027 年，市场可能会开始提前布局一个对光子技术有前景的周期。” 这其实就是我原来的 thesis，没有多余修饰。 上一次 FT 和 Bloomberg 报道我的 $RPI 论点时，他们莫名其妙给贴上“meme stock”的标签，还硬加了不少我根本没说过的话，直接带来负面情绪。 不过话说回来： $SOI 基本上是 CPO 衬底层上的虚拟垄断。 未来一两年我会继续持有，因为我预计它会成为 $NVDA 主导的下一轮架构起量中的最大受益者。
英文原文
Thank you MarketScreener for actual coverage of $SOI this time. The article writes: “In the post dedicated to Soitec, the author puts forward several arguments. He believes that the group could benefit from the development of CPO (co-packaged optics), a photonic architecture designed to accompany the rise of artificial intelligence and data centers. According to him, Soitec would have a quasi-monopolistic position on certain SOI substrates used in this technology, an advantage that could become strategic if photonics is adopted on a large scale. The investor also mentions a valuation level that he considers low and believes that the market could begin to position itself ahead of a promising cycle for photonics by 2027” This was exactly the thesis, no extra fluff. Last time media from FT and Bloomberg covered my thesis on $RPI, they labeled it a “meme-stock” out of nowhere. With many outlets straight up adding words never stated, which triggered negative sentiment. That being said: $SOI is a virtual monopoly over the substrate layer for CPO. I plan to hold my positions over the next year or two, as I expect it to be the largest beneficiary of the upcoming architectural ramp spearheaded by $NVDA.
-
认为方向性做空已被可转债套利部分对冲
@r700cancer 大多数都是方向性做空，已经算进可转债套利里了。 而且利用率也有 80%。
英文原文
@r700cancer Most are directional shorts, factored in the convertible arbitrage. 80% utilized too. https://t.co/Mxj1QOsQny
-
LWLG虽与TSEM整合重要，但从零收入和投机角度看风险较高
我已经研究过$LWLG了。对我个人来说，没有披露任何财务条款，而且这只是一个整合合作关系。所以从零收入角度来看太投机了，像Soitec这样的公司已经通过供应链把产品卖给$NVDA，价值也没比这高多少。但人们可以自由承担这个风险。不过话说回来，$TSEM的整合对他们的公司来说是非常重要的。
英文原文
Already looked into $LWLG. For me personally, there’s no disclosed financial terms and it’s an integration partnership. So too speculative off zero revenue, companies like Soitec already pass through supply to $NVDA and aren’t worth that much more. But people are free to take that risk. That being said the $TSEM integration is extremely material for their company.
-
从基本面角度看 HIMS，但空头挤压风险很高
我一直想从基本面角度聊 $HIMS。 但有一点必须强调： $HIMS 的方向性空头现在像被困住了。 股价已经涨了 64.15%，到 26.5 美元了（虽然仍比 70 多美元的高点低）。 与此同时，空头持仓却增加到了创纪录的 41.6%。 这可能会形成剧烈的反馈回路，因为空头会越来越浮亏。 不过，这一切都取决于股价能否继续被买盘和基本面改善推高；只有这样，他们才会被迫平仓。 否则如果价格横盘，他们可以在很长时间里继续维持空头头寸（借券成本也低），然后慢慢回补。 话虽如此，我个人还是在场，挺期待看看 $HIMS 能交出什么： 一方面是最近类似 $META 的全球并购扩张； 另一方面是类似 $HOOD 的交叉销售潜在收入机会。 随着 $HIMS 在 $NVO 意外合作之后基本面快速改善，我个人真的觉得它有机会创造历史。
英文原文
I try to talk about $HIMS from a fundamental standpoint. But this cannot be understated: $HIMS directional shorts look trapped. The stock price is now up 64.15% to $26.5 (still down from highs of $70s). While short interest increased to record highs of 41.6%. There may be a violent feedback loop as short positions go more underwater. However; this is contingent on the underlying stock going up from buying pressure and increasing fundamentals. In order for their positions get liquidated. Otherwise, if prices stagnates, they can leave their short sales in for extended periods of time (low borrow rate) and slowly buy to cover. That being said, I'm personally along for the ride and looking forward to seeing what $HIMS can deliver: Both from their recent $META-like global acquisitions spree + $HOOD-like cross selling latent revenue opportunities. With $HIMS rapidly improving fundamentals, from the surprise $NVO partnership: I personally see a real opportunity for $HIMS to make history.
-
认为 TSEM 可能重估到 350 亿美元市值
@PhotonCap 哦对，我很喜欢 $TSEM。 我觉得它有机会重估到 350 亿美元市值，大概是现在的 2.5 倍。 感觉只是时间问题，也许再过一年半左右？
英文原文
@PhotonCap Oh yeah I like $TSEM. I think it could get rerated to $35B MC which is like 2.5x from here. Feels like a matter of time, maybe another year and a half?
-
更喜欢 SOI 的弹性，但也看好 TSEM 的去风险化
@AtlasShrug1 我也更偏好 $SOI，因为它的上行空间更大。 不过，$TSEM 体量更大，而且我觉得它因为产能积压和 $NVDA 的双重支撑，已经明显去风险了。 而且我也看到它未来两年会强劲复合增长，所以就在这个位置做多了。
英文原文
@AtlasShrug1 I prefer $SOI as well, much higher upside. However, $TSEM is much larger player but I see it being very de-risked from both backlogged capacity + $NVDA. And I do see this strongly compounding over the next two years so I went long around here.
-
看多 Tower Semi 作为光子代工层的非对称机会
我做多 $TSEM，把它看成光子领域里的 $TSM。 我最看好的两只 CPO 标的是 $SOI 和 Tower Semi。 考虑到下周 $NVDA GTC 会有关于新光子架构的催化，我预计 Tower Semi 会迎来很强的催化。 Nvidia 上个月已经直接和 Tower 合作扩展 1.6T 硅光，这几乎就是在给 GTC 提示，随后很可能推动下游玩家采用它。 而现在，Tower 已经是 1.6T SiPh PIC 的领先供应商，也是规模化 CPO 架构的主要代工厂（另一个是 GlobalFoundries）。 根据我的前瞻估算： 2028 年前瞻 PE 约为 16.8 倍到 18.1 倍。 （Tower 目标到 2028 年实现 28.4 亿美元收入，经营利润率约 31.7%，净利润约 7.5 亿美元。） 要注意的是，他们计划中的 SiPh 产能已有 70% 以上被预订到 2028 年了，而光子业务甚至还没真正起量。 所以我预计，随着光子产能极度扩张以及分配价格上调，而这些还没被模型完全计入，Tower 的盈利会明显超预期。 另外，$TSEM 因为 70% 产能已被预订，实际上风险已经大幅下降。 它的市值之所以还低，很大程度上是因为它是光子供应链里非常冷门的上游玩家。 但我预计 $NVDA GTC 会成为把它推向溢价估值的催化剂。 我做多 $TSEM，是把它当成上游光子代工层的非对称上行标的。
英文原文
I'm long $TSEM, the $TSM of photonics. My top two picks for CPO are $SOI and Tower Semi. Given the $NVDA GTC catalyst on new photonic related architecture next week: I expect Tower Semi to get a huge catalyst. Nvidia laready directly collaborated with Tower to scale 1.6T silicon photonics last month (hint hint for GTC), likely pushing the downstream players to use it. And now, Tower is the leading supplier of 1.6T SiPh PICs and the primary foundry for scale-up CPO architectures. (the other being global foundries) From my forward est: 2028 Forward P/E: ~16.8x to ~18.1x (Tower set a target $2.84B revenue by 2028, with ~31.7% operating margin, ~$750M in net profit) The thing to note is over 70% of their planned SiPh capacity is already reserved through 2028. And photonics haven't even ramped up yet. So, I expect them to strongly beat earning projections due to extreme photonics scaling + allocations price hikes that's not modeled into projections. Also, $TSEM is heavily de-risked by 70% of capacity already being reserved. MC is likely due to $TSEM being a very obscure upstream player in the photonics supply chain. But I expect the $NVDA GTC conference to be that catalyst that brings it to premium valuations. I'm long $TSEM as an asymmetrical upside for upstream photonics foundry layer.
-
补充说如果周一问会把 AXTI 也算进去
@Meatusmax @jaegerjaque7 他们是今天才问的。 $AXTI 已经是历史新高了，要是周一问我，我当时就会把它算进去。
英文原文
@Meatusmax @jaegerjaque7 They said today. $AXTI is all time high, if they asked me Monday I would have included it
-
列出自己最喜欢的一篮子名字
@jaegerjaque7 $SOI、$AAOI、SK 海力士、$RDDT、$HIMS
英文原文
@jaegerjaque7 $SOI, $AAOI, SK Hynix, $RDDT, $HIMS
-
认为 IREN 上行受 60 亿 ATM 限制，NBIS 融资结构更好
不是说 $IREN 会崩。 更准确地说，短中期里 IREN 的上行空间会被 60 亿美元 ATM 限制住。 如果你要投 IREN，最好等现有持有人被高达 60 亿美元的卖压稀释得差不多之后，再去做多。 如果你追求股权升值，$NBIS 的资本开支融资结构要好得多。
英文原文
It’s not that $IREN will crash. It’s moreso short-medium term IREN’s upside is capped due to the $6B ATM. If you’re investing in IREN it’s better to wait after existing holders get diluted to oblivion from up to $6B in selling pressure, then go long after. If you’re chasing equity appreciation, $NBIS has a much superior capex financing structure.
-
感叹 AXT 从 12 美元涨到 46 美元
@banker092 我也不知道，$AXTI 已经从 12 美元涨到 46 美元，而且看起来根本没停过。
英文原文
@banker092 Idk $AXTI got sent from $12 to $46 and hasn’t looked back
-
反驳称 Soitec 被低估且是光子链垄断者
@AtlasShrug1 我会说那位分析师当时对 $SOI 的判断并不懂行——如果它的账面市值比只有 1 倍、PS 只有 2 倍，而且还是 CPO 的垄断者，那就更说明如此。 不是每个人都懂光子供应链。
英文原文
@AtlasShrug1 I’d say that analyst didn’t know what they were talking about then with $SOI if it trades at 1x book value, 2x P/S and is a monopoly over cpo. Not everyone has domain expertise in photonic supply chains
-
把 KRKNF 当交易想法，仍偏好 Soitec
@Noobverest 那些只是交易思路，我自己并没有持有像 $KRKNF 这种票。 不过我确实喜欢 Octopus。 $SOI 是我高信念的光子多头！
英文原文
@Noobverest Those were just trade ideas, I don’t have positions in stuff like $KRKNF. I did like Octopus though $SOI was high conviction photonics long!
-
调侃自己发帖后 Soitec 涨了 20%
一个普通人在网上发了下自己对市值数十亿美元公司 $SOI 的看法…… 结果它就涨了 20%。 我现在这么强了吗？
英文原文
How does a random person posting their thoughts on a multi billion dollar company $SOI … Send it up 20% Am I that powerful now? https://t.co/fltXyAOyxC
-
对比 NBIS 与 IREN 的融资结构，认为前者更优
$NBIS 和 $IREN 的差别，简直天壤之别。 Nebius：来自 $NVDA 的 20 亿美元稀释，没有立刻对公众流通盘形成卖压。 IREN：通过 ATM 稀释 60 亿美元，卖压直接打进公开市场。 这会直接从公众手里抽走流动性，并压制动量。 谁更能通过资本开支融资带来更高的股价升值，已经非常清楚了。 一个是与 Nvidia 的战略合作，另一个是有毒融资。
英文原文
$NBIS vs. $IREN. The difference is night and day. Nebius: $2B dilution from $NVDA, zero immediate selling pressure to the public float Iren: $6B dilution from ATM into selling pressure into the open market. This extracts liquidity directly from the public and suppresses momentum Very clear, which company leads to higher share value appreciation from capex financing. One is strategic with Nvidia, the other is toxic financing.
-
认为做空 HIMS 是极其愚蠢的
做空者方向性加仓 $HIMS，真是蠢到家了。 他们最近的收购直接给 $HIMS 带来了全球 DTC 医疗零售市场。 交叉销售机会极其潜在，而且很难建模。 在这种情况下，这根本不是你平常那种有对冲的套利交易，所以风险管理非常差。
英文原文
Extremely stupid for short sellers to directionally double down on $HIMS. Their recent acquisitions just gave $HIMS the global retail market for DTC healthcare. The cross selling opportunities are extremely latent and hard to model. So very bad risk management, given it’s not your typical hedged arbitrage trade.
-
认为 MRVL 受益有限，更看好 Soitec 和 TSEM
@siflower 你从 $MRVL 能拿到的直接敞口其实很有限。Celestial 的收入大约是 2028 年 5 亿美元、2029 年 10 亿美元。 Marvell 的大部分收入起量来自到 2028 年的 $MSFT Maia 和 ASIC，不过它依然是一只很棒的多头。 至于 CPO，我觉得 Soitec 和 $TSEM 大概是两个更关键的名字。
英文原文
@siflower You're getting very minimal exposure from $MRVL. Celestial revenue was ~$500m 2028, $1B 2029. Most of Marvell's revenue ramp comes from $MSFT Maia and ASICs toward 2028, but it's an amazing long nevertheless. For CPO Soitec and $TSEM are probably the two.
-
分析$CODA稳健基本面，伊朗布雷事件为声纳探测板块带来重大利好。
也不尽然，$CODA 看起来基本面非常稳健。现金储备充足，净收入为正，而且对于这个行业+传感器来说利润率极高。如果说有什么的话，伊朗在霍尔木兹海峡(Strait)布雷刚刚给声纳/探测类股票（如$CODA和$KRKNF）带来了十年来最大的利好。委内瑞拉的战争更多聚焦于无人机，如$AVAV，而且从未真正涉及水下领域。所以这可能是第一次让所有人看到这些应用的机会+导致更多资金流入该板块，尽管整体市场规模(TAM)并没有真正扩大太多。
英文原文
Not exactly, $CODA looks very fundamentally sound. High cash balance, net income positive, and extremely high margins for the sector + sensors. If anything, Iran placing mines in the Strait just gave sonar/detection stocks like these and $KRKNF the biggest tailwind of the decade. Warfare in Venezulea focused more on drones like $AVAV and never really went underwater. So this is probably one of the first times everyone sees the applications now + leads to more sector inflows, even if TAM didn't exactly increase too much.
-
伊朗霍尔木兹海峡布雷，推荐两只水下战争纯正标的$KRKNF和$CODA，均有优质基本面。
10分钟前来自Reuters的消息： 消息人士新确认伊朗已在霍尔木兹海峡部署了约十枚水雷。 我发现有两只水下 warfare（海上战争）股票很有意思，可以提供敞口。 $KRKNF 章鱼🦑和$CODA 水母。 $KRKNF：Kraken Robotics，Anduril（安杜里尔）的供应商，是海上战争领域最纯正的标的之一： 他们生产合成孔径声纳(SAS)和SeaPower电池，许多防务主承包商如Anduril都依赖这些。 Anduril最近在罗德岛开设了一家工厂，用于大规模生产UUV（无人水下航行器）（如Dive-LD和Ghost Shark）。 根据零售端BOM估算： - Dive-LD携带价值1M至2M加元的Kraken硬件 - Ghost Shark XL-AUV携带价值8M至10M加元。 如果Anduril实现量产：收入增长是可期的。 我不会基于收入预测来建模Kraken，而更像看Anduril能扩展到多大（类似于用$GOOGL的TPU来建模$LITE）。 但财务状况、资产：3.015亿美元，负债：6570万美元，总债务约2410万美元，看起来相当健康。毛利率59%的基础上实现60%的年度收入增长。 至于在海峡排雷，他们有KATFISH猎雷无人机。以及用于生成海底3D图像的SAS声纳，用于识别埋藏的水雷。 $CODA：Coda Octopus，基本上是伊朗布雷这一情境的纯正敞口。 他们的主要产品是Echoscope实时3D/4D/5D体积声纳，可在浑浊、漆黑的水中绘制静态和移动物体的图像。 这一技术延伸至其他产品如"NANO Gen Series"，即作为UUV感知传感器的Echoscope版本。 还有一个供潜水员使用的增强显示设备（SPECWAR已订购），基本上就是将Echoscope声纳数据反馈给人员。 CODA的资产负债表非常亮眼。最新FY2025报告（截至2025年10月），他们持有2870万美元的纯现金，且没有长期债务。 毛利率也非常高，综合毛利率66.5%，而大多数防务承包商只有10-20%。 2025年收入2660万美元，同比增长30.7%，净利润410万美元，能实现盈利实属难得。 基本上他们的声纳/探测产品组合对于这个具体情境来说是非常纯粹的标的，即使没有这个催化剂，基本面也非常扎实。 无论如何，伊朗在海峡布雷并不是一个重大的TAM（总可寻址市场）增加。 然而，它确实提醒投资者和政府，战争可能转向水下： 从而带来更多板块资金流入以及防务合同机会。 这些是我个人的两只最爱，既然发表了看法，也希望对其他人有帮助。
英文原文
Just in 10M ago from Reuters: New confirmation from sources that Iran has deployed about a dozen mines in the Strait of Hormuz. There's two very aquatic warfare stocks I found interesting for exposure. $KRKNF the Squid🦑and $CODA the Octopus. $KRKNF: Kraken Robotics, the Andruil supplier, is one of the more pure play stocks for the acquatic warfare sector: They build Synthetic Aperture Sonar (SAS) and SeaPower batteries that many defense primes like Andruil rely on. Anduril recently opened a facility in Rhode Island to mass produce UUVs (eg. Dive-LD and Ghost Shark). According to retail BOM estimates: - Dive-LD carries $1M to $2M CAD in Kraken hardware - Ghost Shark XL-AUV carries $8M to $10M CAD. If that Anduril ramps happens: the revenue ramp is there. I wouldn't try and model Kraken based off revenue projections but more like how much Andruil scales (similar modeling $LITE based on $GOOGL TPU) But financials, assets: $301.5M, Liabilities: $65.7M, Total debt: ~$24.1M so looks pretty healthy. 60% YoY revenue growth off 59% gross margins. As for demining the strait, they have the KATFISH mine-hunting drone. And SAS Sonar for 3D images of the seafloor for identifying buried mines. $CODA: Coda Octopus, basically pure play exposure to Iran placing mines. Their main product is Echoscope real-time 3D/4D/5D volumetric sonar that maps static and moving objects in murky, pitch-black water. This carries forward to other products like "NANO Gen Series", Echoscope version as a perception sensor for UUVs. And then a diver augmented display (that SPECWAR ordered), which is basically the Echoscope sonar feeding people data. CODA has an amazing balance sheet. Recent FY2025 report (ending Oct 2025), they hold $28.7 million in pure cash and have zero long-term debt. Gross margins are extremely high as well, consolidated gross margin of 66.5% while majority of defense contracotrs sit around 10-20%. $26.6M revenue for 2025, 30.7% Y/Y increase, and $4.1M net income, which is rare to be profitable. But basically their product set of sonar / detection looks perfect pure play for this exact scenario and they’re fundamentally very sound, without the catalyst. Regardless, Iran mining the straight isn't exactly a major TAM increase. However, it does alert investors and the government that warfare may transition underwater: Leading to more sector inflows as well as defense contract opportunities. These were my two favorites personally, just publishing my thoughts here in case other's find this helpful.
-
解释 ClickHouse 其实是 Nebius 内部项目分拆
@offermemoneyXYZ ClickHouse 其实原本是 Nebius 旗下的内部项目，后来才分拆成独立公司。 $NBIS 持有 ClickHouse 约 25% 股份，按 150 亿美元估值计算，这个市值后面大概率还会往更高走，至少要到它可能 IPO 之前。
英文原文
@offermemoneyXYZ Clickhouse was actually an internal project run by Nebius, but it spun off as an independent company. $NBIS owns ~25% of Clickhouse at $15B valuation, and that MC is likely go up lots higher up until their possible ipo.
-
调侃 IQE 涨太多了需要休息
@ryansfinance $IQE 从上个月开始已经涨了 136% 了，哈哈，有时候确实得歇一歇。 不是我所有的票都能像 $AAOI 或 $AXTI 那样每天直线往上冲 8%。
英文原文
@ryansfinance $IQE is literally up 136% since last month lol, sometimes things need a break. Not all my picks like $AAOI or $AXTI can go in a vertical line up 8% a day. https://t.co/lxJqKT5b5e
-
认为 Soitec 因光子垄断继续大涨只是开始
看来市场确实喜欢隐藏的光子垄断？ Soitec 盘中又涨了 16%。 如果你看 $NVDA 主导的 CPO 光子架构起量：这几乎是抛物线式的。 $SOI 很可能会成为一只可以拿很多年的票，因为它是 CPO 的衬底垄断者。 而且最重要的是，下周还有即将到来的 $NVDA GTC 发布会。 这大概率会提醒机构去寻找他们错过的玩家，比如 $AXTI，现在再加上 $SOI。
英文原文
Turns out markets like hidden photonics monopolies? Soitec is up 16% intraday. If you look at the CPO photonics architectural ramp led by $NVDA: It’s parabolic. $SOI is likely a name that people can hold for many years as the substrate monopoly for CPO. And best of yet, there’s the upcoming $NVDA GTC announcement next week. Which would likely signal to institutions to start looking into players they missed like $AXTI, and now $SOI.
-
继续看多 HIMS 的商业化潜力与空头挤压
$HIMS 现在又涨回了 14.22%。 他们全球 DTC 零售分发护城河中尚未释放的潜在收入极其惊人。 这也让人联想到 $META 早期的并购，以及 $HOOD 的交叉销售能力。 $HIMS 仍然比 70 多美元的高点低不少，但它已经通过收购三家全球主要竞争对手，而且几乎没有监管阻力。 更妙的是：那些把 40%+ 流通盘方向性做空的空头，已经被 $NVO 的意外合作和诉讼终止彻底困住了。 我个人会在这里继续持有并做多 HIMS。 如果管理层真能把这张全球零售分发网络有效变现，用在医疗上，这个风险回报是值得的。
英文原文
$HIMS is now back up 14.22%. The untapped latent revenue from their their global DTC retail distribution moat is extreme. And draws parallels to the early acquisitions from $META. As well as the cross-selling capabilities of $HOOD. $HIMS is still down from it's $70+ highs, after acquiring three major global competitors without regulatory friction. And best of yet: Shorts that sold 40%+ of the company short directionally, are completely trapped from the surprising $NVO partnership + lawsuit termination. I would personally hold and go long here on HIMS. The risk/reward on management effectively monetizing that massive, global retail distribution network for healthcare seems worth it.
-
认为 Nvidia 对 Nebius 的 20 亿投资是极强信号
@beauty_oe 考虑到 $NBIS 的市值，$NVDA 投入 20 亿美元是一个极其巨大的动作，也足以成为他们未来成长的超强信号！ Nebius 是我最喜欢的长期标的之一，用来押注 AI 未来的敞口。
英文原文
@beauty_oe $NBIS の時価総額を考えると $NVDA による20億ドルの投資はとてつもなく大きく、彼らの今後の成長を裏付ける超強力なシグナルだ！Nebiusは、AIの未来にエクスポージャーを取るための長期銘柄として一番のお気に入り
-
认为 Nebius 是下一家 AWS 级超大规模云
最新消息：Nvidia 向 $NBIS 投资了 20 亿美元。 我确信 Nebius 终将成为下一家 Amazon 级别的超大规模云。 因为它其实是 5 家业务的组合，而且这些业务的部分总和都在以三位数同比增长： - Nebius：AI Cloud，7 到 90 亿美元 ARR，正朝着下一个 AWS 发展 - ClickHouse：支撑大多数财富 500 强公司的数据库，上一轮估值 150 亿美元 - Avride：Robotaxi 和 FSD-4 级技术，现在正和 Uber 一起实车放量 - Toloka：数据标注平台，得到了 Jeff Bezos 的资金支持，也被 $AMZN 使用 - TripleTen：教育平台，虽然没那么性感，但增长也很快 另外还有像 SWE-rebench 这类广泛使用的 benchmark 之类的 side quests。 Jensen 对 Nebius 的 $NVDA 投资表达的也是同一个意思：Nebius 站在 AI 前沿，正引领浪潮去满足不断增长的算力需求。
英文原文
Just in: Nvidia has invested $2B into $NBIS. I'm convinced Nebius is the next Amazon-level hyperscaler over time. As they're 5 companies all growing sum-of-parts triple digits Y/Y: - Nebius: $7-9B ARR from AI Cloud as the next AWS. - Clickhouse: DB powering majority of fortune 500 companies, last valuation at $15B - Avride: Robotaxi and FSD-4 level technology, now scaling up live with Uber. - Toloka: Data Labeling platform, funded by Jeff Bezos and used by $AMZN - TripleTen: Education platform, not as sexy as the rest, but still fast growing. With sidequests from the widely used benchmarks like SWE-rebench. Jensen's $NVDA investment into Nebius shares the same sentiment: Nebius is at the forefront of AI and leading the wave to meet the growing demand for compute.